Injectable peptides are the new anti-aging trend sweeping the beauty industry. These compounds are promoted on social media ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re considering a semaglutide medication like Ozempic or Wegovy for weight loss, you may be a bit worried about the weekly ...

Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...

University of Cincinnati researchers found extended-release buprenorphine helped pregnant women avoid illegal opioids better ...

Dr Memee Ahmad has issued a warning over the use of peptide injection after they become the latest ‘looksmaxxing’ trend ...

Novo got approval for the higher dose of its Wegovy injection in March based on results from a late-stage clinical trial in which 89% of participants taking the higher dose achieved 5% or greater ...

Stelara (ustekinumab) is a brand-name prescription drug approved to treat Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. You should always administer Stelara according ...

A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by researchers. It promises easier treatment, fewer missed doses, and better ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what’s the difference? And which form is more effective for weight loss? Semaglutide ...

Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health ...

New 2026 Program Overview Details Compounded NAD+ Therapy Access, Three-Entity Telehealth Structure, and What Patients Should ...